These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28161128)

  • 21. Evaluation of a new hemoglobin A1c analyzer for point-of-care testing.
    Zhou R; Wang W; Song ZX; Tong Q; Wang QT
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28220976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How can point-of-care HbA1c testing be integrated into UK primary care consultations? - A feasibility study.
    Hirst JA; Stevens RJ; Smith I; James T; Gudgin BC; Farmer AJ
    Diabetes Res Clin Pract; 2017 Aug; 130():113-120. PubMed ID: 28602811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Random blood glucose may be used to assess long-term glycaemic control among patients with type 2 diabetes mellitus in a rural African clinical setting.
    Rasmussen JB; Nordin LS; Rasmussen NS; Thomsen JA; Street LA; Bygbjerg IC; Christensen DL
    Trop Med Int Health; 2014 Dec; 19(12):1515-9. PubMed ID: 25294180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND.
    Konig M; Riddle MC; Colhoun HM; Branch KR; Atisso CM; Lakshmanan MC; Mody R; Raha S; Gerstein HC
    Cardiovasc Diabetol; 2021 Sep; 20(1):194. PubMed ID: 34563178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
    Kennedy L; Herman WH; Strange P; Harris A;
    Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the effect of altitude on the measurement of glycated haemoglobin using point-of-care instruments.
    Veigne SW; Sobngwi E; Nouthe BE; Sobngwi-Tambekou J; Balti EV; Limen S; Dehayem MY; Ama V; Nguewa J; Ndour-Mbaye M; Camara A; Balde NM; Mbanya J
    Cardiovasc J Afr; 2015; 26(1):38-40. PubMed ID: 25784316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA
    Abildgaard A; Knudsen CS; Bjerg LN; Lund S; Støy J
    Clin Chem Lab Med; 2022 Jan; 60(1):127-134. PubMed ID: 34480844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HbA
    Dubach IL; Christ ER; Diem P
    Prim Care Diabetes; 2019 Dec; 13(6):583-587. PubMed ID: 31175054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation between Point-of-care and Laboratory HbA1c testing in Clinical Practice.
    Fellows SE; Cipriano GC
    P R Health Sci J; 2019 Sep; 38(3):189-191. PubMed ID: 31536634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The frequency of testing for glycated haemoglobin, HbA1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus.
    Duff CJ; Solis-Trapala I; Driskell OJ; Holland D; Wright H; Waldron JL; Ford C; Scargill JJ; Tran M; Hanna FWF; Pemberton RJ; Heald A; Fryer AA
    Clin Chem Lab Med; 2018 Dec; 57(2):296-304. PubMed ID: 30281512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study.
    Fangel MV; Nielsen PB; Kristensen JK; Larsen TB; Overvad TF; Lip GYH; Jensen MB
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007030. PubMed ID: 30995869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study.
    Barron E; Misra S; English E; John WG; Sampson M; Bachmann MO; Barth J; Oliver N; Alberti KGMM; Bakhai C; O'Neill S; Young B; Wareham NJ; Khunti K; Jebb S; Smith J; Valabhji J
    BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33318069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mean HbA
    Forbes A; Murrells T; Mulnier H; Sinclair AJ
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy and Precision of a Point-of-Care HbA1c Test.
    Arnold WD; Kupfer K; Little RR; Amar M; Horowitz B; Godbole N; Hvidsten Swensen M; Li Y; San George RC
    J Diabetes Sci Technol; 2020 Sep; 14(5):883-889. PubMed ID: 30854894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between self-monitored mean blood glucose and average plasma glucose estimated from glycated haemoglobin in patients attending the diabetes clinic at Dr George Mukhari Academic Hospital, Pretoria, South Africa.
    Nkoana MK; Khine AA
    S Afr Med J; 2020 Apr; 110(5):416-421. PubMed ID: 32657728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of point-of-care HbA1c test versus standardized laboratory testing.
    Sicard DA; Taylor JR
    Ann Pharmacother; 2005 Jun; 39(6):1024-8. PubMed ID: 15840733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between number of contacts between previous dropouts with type 2 diabetes and health care professionals on glycaemic control: A cohort study in public primary health care.
    Kauppila T; Eriksson JG; Honkasalo M; Raina M; Laine MK
    Prim Care Diabetes; 2019 Oct; 13(5):468-473. PubMed ID: 30928432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring reasons for very poor glycaemic control in patients with Type 2 diabetes.
    Khan H; Lasker SS; Chowdhury TA
    Prim Care Diabetes; 2011 Dec; 5(4):251-5. PubMed ID: 21782539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial.
    Bubner TK; Laurence CO; Gialamas A; Yelland LN; Ryan P; Willson KJ; Tideman P; Worley P; Beilby JJ
    Med J Aust; 2009 Jun; 190(11):624-6. PubMed ID: 19485840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.